ALAUNOS THERAPEUTICS
ALAUNOS THERAPEUTICS
Social Links:
Industry:
Biotechnology
Address:
Houston, Texas, United States
Country:
United States
Website Url:
http://www.alaunos.com
Total Employee:
11+
Status:
Active
Current Employees Featured
Key Employee Changes
Official Site Inspections
http://www.alaunos.com Semrush global rank: 7.4 M Semrush visits lastest month: 509
- Host name: 161.0.153.160.host.secureserver.net
- IP address: 160.153.0.161
- Location: Scottsdale United States
- Latitude: 33.6013
- Longitude: -111.8867
- Metro Code: 753
- Timezone: America/Phoenix
- Postal: 85260
More informations about "Alaunos Therapeutics"
IR Landing Page – Alaunos
Developing non-viral gene transfer-based cell therapies to effectively access and treat the millions of people diagnosed globally each year with solid tumors by …See details»
Alaunos Therapeutics - Crunchbase Company Profile & Funding
Alaunos Therapeutics is a biotechnology company that acquires, develops, and commercializes cancer therapies.See details»
Alaunos Therapeutics, Inc. - Drug pipelines, Patents ... - Patsnap
Jul 10, 2025 About Alaunos Therapeutics, Inc.Alaunos is a preclinical stage obesity and metabolic health drug development company that is aiming to develop a small molecule-based …See details»
Alaunos Therapeutics - 2025 Company Profile & Team - Tracxn
Jul 6, 2025 Explore Alaunos Therapeutics' in-depth company profile, including funding details, key investors, leadership, and competitors.See details»
Alaunos Therapeutics, Inc.: Governance, Directors and Executives ...
Alaunos Therapeutics, Inc. is a clinical-stage oncology-focused cell therapy company. The Company is focused on exploring strategic alternatives, including, but not limited to, an …See details»
Alaunos Therapeutics Company Profile - Office Locations ... - Craft
See insights on Alaunos Therapeutics including office locations, competitors, revenue, financials, executives, subsidiaries and more at Craft.See details»
Alaunos Therapeutics Inc Company Profile - Overview
Alaunos Therapeutics Inc (Alaunos Therapeutics) is a clinical stage cellular immuno-oncology company that focuses on developing innovative T-cell therapies for cancer treatment. Its …See details»
CONTACT – Alaunos
ANALYST COVERAGE INVESTOR FAQS Contact Alaunos Therapeutics, Inc. 2617 Bissonnet St Suite 225 Houston, TX 77005See details»
Alaunos Therapeutics
Jul 17, 2025 Founded in 2016, Alaunos Therapeutics is a clinical-stage biopharmaceutical company focused on the development of novel therapies for serious, life-threatening diseases. …See details»
Alaunos Therapeutics - LinkedIn
Alaunos is a clinical stage cellular immuno-oncology company dedicated to the treatment of solid tumors through adoptive TCR-T cell therapy. With our …See details»
Alaunos Therapeutics | VentureRadar
Alaunos is a clinical stage cellular immuno-oncology company dedicated to the treatment of solid tumors through adoptive TCR-T cell therapy. With our robust and innovative discovery engine, …See details»
Alaunos Therapeutics. Information about the issuer. . News and …
Organization name Alaunos Therapeutics Inc (formerly ZIOPHARM Oncology, Inc.) Country name USA Country of registration USA Industry Pharmaceutical Preparation and Biotechnology …See details»
SEC Filings | Alaunos
Jul 22, 2025 The Investor Relations website contains information about Alaunos's business for stockholders, potential investors, and financial analysts.See details»
Alaunos Therapeutics Overhauls Leadership: New CEO Holger …
Jul 2, 2025 Alaunos Therapeutics has appointed Holger Weis as its new Chief Executive Officer, effective July 2, 2025, succeeding Dale Curtis Hogue, Jr., who transitions to a consulting role. …See details»
OUR APPROACH – Alaunos
Our approach is focused on T-cell receptors, or TCRs, from discovery to clinical translation as TCR-T cell therapies and beyond, creating the next generation of TCR-T cells. We target the …See details»
Alaunos Therapeutics - VentureRadar
"Alaunos is a clinical stage cellular immuno-oncology company dedicated to the treatment of solid tumors through adoptive TCR-T cell therapy. With our robust and innovative discovery engine, …See details»
OUR SCIENCE – Alaunos
Alaunos’ hunTR ® (hu man n eoantigen T -cell R eceptor) platform enables the rapid identification of new, wholly owned TCRs to further expand the Company’s growing TCR library. hunTR ® is …See details»
Quarterly Results | Alaunos
The Investor Relations website contains information about Alaunos's business for stockholders, potential investors, and financial analysts.See details»
PARTNERSHIPS – Alaunos
Alaunos is developing our Sleeping Beauty platform in collaboration with The University of Texas MD Anderson Cancer and the National Cancer Institute.See details»
Privacy Policy – Alaunos
Alaunos may also exchange such data with you over the internet or over intranet systems for the purposes of processing the data, mailing information to you in response to your request, or …See details»